Cresilon, Inc. — Form D/A
Cresilon, Inc. of BROOKLYN, NY, a company, filed a Form D amendment with the SEC on 2026-06-26. The offering totals $29.0M, of which $29.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-06-26
- Form: D/A
- Accession: 0001728054-26-000002
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $29.0M
- Amount sold: $29.0M
- Remaining: $801
- Minimum investment: $10K
- Investors: 217
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-582305
Issuer
- Name: Cresilon, Inc.
- CIK: 0001728054
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 122 18TH STREET Suite 6-3-D, BROOKLYN, NY, 11215
- Phone: (347) 435-2226
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Scott Levine | Executive Officer | Brooklyn, NY |
| Scott Levine | Related Person | Brooklyn, NY |
| Isaac Miller | Director | Brooklyn, NY |
| Isaac Miller | Executive Officer | Brooklyn, NY |
| Isaac Miller | Related Person | Brooklyn, NY |
| Joseph Landolina | Director | Brooklyn, NY |
| Joseph Landolina | Executive Officer | Brooklyn, NY |
| Joseph Landolina | Related Person | Brooklyn, NY |
Other filings by this issuer (8)
More